Changes in pharmacovigilance following the end of the Brexit transition

Bibliographic Details
Main Author:	Sarah Hall
Format:	Article
Language:	English
Published:	SAGE Publishing 2021-09-01
Series:	Therapeutic Advances in Drug Safety
Online Access:	https://doi.org/10.1177/20420986211042208

id	doaj-14f81c8f4ab544f580a72ae6a3ce29af
record_format	Article
spelling	doaj-14f81c8f4ab544f580a72ae6a3ce29af2021-09-21T21:33:49ZengSAGE PublishingTherapeutic Advances in Drug Safety2042-09942021-09-011210.1177/20420986211042208Changes in pharmacovigilance following the end of the Brexit transitionSarah Hallhttps://doi.org/10.1177/20420986211042208
collection	DOAJ
language	English
format	Article
sources	DOAJ
author	Sarah Hall
spellingShingle	Sarah Hall Changes in pharmacovigilance following the end of the Brexit transition Therapeutic Advances in Drug Safety
author_facet	Sarah Hall
author_sort	Sarah Hall
title	Changes in pharmacovigilance following the end of the Brexit transition
title_short	Changes in pharmacovigilance following the end of the Brexit transition
title_full	Changes in pharmacovigilance following the end of the Brexit transition
title_fullStr	Changes in pharmacovigilance following the end of the Brexit transition
title_full_unstemmed	Changes in pharmacovigilance following the end of the Brexit transition
title_sort	changes in pharmacovigilance following the end of the brexit transition
publisher	SAGE Publishing
series	Therapeutic Advances in Drug Safety
issn	2042-0994
publishDate	2021-09-01
url	https://doi.org/10.1177/20420986211042208
work_keys_str_mv	AT sarahhall changesinpharmacovigilancefollowingtheendofthebrexittransition
_version_	1717371988352172032

Similar Items